Filing Details
- Accession Number:
- 0001099219-24-000076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-14 16:35:47
- Reporting Period:
- 2024-03-13
- Accepted Time:
- 2024-03-14 16:35:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1099219 | Metlife Inc | MET | Life Insurance (6311) | 134075851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1714199 | Ramy Tadros | Metlife, Inc. 200 Park Avenue New York NY 10166 | President, U.s. Business | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-03-13 | 4,026 | $71.90 | 146,981 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person onDecember 13, 2023.
- The price reported is the weighted average price of the aggregate number of shares sold in multiple open market transactions. The shares were sold at prices between $71.85 to $72.00, inclusive. The reporting person undertakes to provide to the staff of the SEC, MetLife, Inc., or a security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price.